Cochrane Abstracts
Methotrexate for ankylosing spondylitis
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Methotrexate for Ankylosing Spondylitis." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/433806/all/Methotrexate_for_ankylosing_spondylitis.
Methotrexate for ankylosing spondylitis. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433806/all/Methotrexate_for_ankylosing_spondylitis. Accessed January 18, 2025.
Methotrexate for ankylosing spondylitis. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433806/all/Methotrexate_for_ankylosing_spondylitis
Methotrexate for Ankylosing Spondylitis [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 January 18]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/433806/all/Methotrexate_for_ankylosing_spondylitis.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Methotrexate for ankylosing spondylitis
ID - 433806
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/433806/all/Methotrexate_for_ankylosing_spondylitis
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
